Author Archives: Mimi Castellanos

mimi@bravocoop.com Our bodies contain 30 trillion human cells and even more microbial cells.  A ratio of 1 to 1.3!  The  microbiome is half of the volume of us and includes 39 trillion (non-human) cells.  By the time we are 21, we have a unique … Continue reading →

by Ray Dalio   NEWSLETTER ON LINKEDIN Principled Perspectives  By Ray DalioThe Big Cycles Over The Last 500 YearsNote: To make this an easier and shorter article to read, I tried to convey the most important points in simple language and bolded them, so … Continue reading →

Dr. Ruggiero answered: An independent laboratory (R.E.D. Labs, Belgium) demonstrated that Bravo products have 100 fold more GcMAF activity against nagalase than purified GcMAF. These results have been published in a peer-reviewed scientific article where the effects of Bravo on … Continue reading →

This is an educational compilation for Dr. Ruggiero’s product called Edestiny. It was introduced on 3/31/2020. The following items are about Bravo Edestiny: Bravo Coop Stock Order and New Product Announcement 4/22/20 Product Page from Healthy Energetics Shopping Cart “Learn … Continue reading →

From Dr. Marco Ruggiero: BRAVO EDESTINY (CAPSULES) is a product entirely made in Switzerland and contains exclusively ingredients from certified Swiss and European sources; all the microorganisms, probiotic strains, and ingredients in this product are certified safe for human use. They are manufactured … Continue reading →

Furin, a potential therapeutic target for COVID-19  Potential treatment of Chinese and Western Medicine targeting nsp14 of 2019-nCoV  Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells  Transplantation of ACE2- mesenchymal stem cells … Continue reading →

Transplantation of ACE2– mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Zikuan Leng1,5#, Rongjia Zhu2#, Wei Hou3#, Yingmei Feng3#, Yanlei Yang4, Qin Han2, Guangliang Shan2, Fanyan Meng1, Dongsheng Du1, Shihua Wang2, Junfen Fan2, Wenjing Wang3, Luchan Deng2, Hongbo … Continue reading →

Furin, a potential therapeutic target for COVID-19 Canrong WU,a,1Yueying YANG,b,1Yang LIU,bPeng ZHANG,bYaliWANG,bQiqi WANG, b Yang XU,bMingxue LI,bMengzhu ZHENG,a,* Lixia CHEN,b,* &Hua LIa,b,* aHubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science … Continue reading →

Potential treatment of Chinese and Western Medicine targeting nsp14 of 2019-nCoV Chao Liu 1, Xiaoxiao Zhu 1, Yiyao Lu 1, Xu Jia 1*, Tai Yang 2* 1 Non-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, … Continue reading →